MedTrace Logo

Efficacy and Safety Study of Policosanol

NCT02543099 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2015-09-07

No results posted yet for this study

Summary

The purpose of this study is to assess the clinical efficacy and safety of policosanol on elderly patients with endothelial dysfunction

Conditions

  • Endothelial Dysfunction

Interventions

DRUG

policosanol

Patients will receive policosanol 20mg Qd

DRUG

placebo

Patients will receive placebo 20mg Qd;

Sponsors & Collaborators

  • Chinese PLA General Hospital

    collaborator OTHER

  • General Hospital of Chinese Armed Police Forces

    lead OTHER

Principal Investigators

  • ping ye, M.D · Department of geriatric Cardiology, Chinese PLA general hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2016-04-30
Completion
2016-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02543099 on ClinicalTrials.gov